Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience

Objective. To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy. Methods. Nonrandomized retrospective interventional case series. Thirteen patients with...

Полное описание

Библиографические подробности

Главные авторы:	Miguel Cordero-Coma, Vanesa Calvo-Río, Alfredo Adán, Ricardo Blanco, Carolina Álvarez-Castro, Marina Mesquida, Sara Calleja, Miguel A. González-Gay, José G. Ruíz de Morales
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2014-01-01
Серии:	Mediators of Inflammation
Online-ссылка:	http://dx.doi.org/10.1155/2014/717598
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!